News Results (top 2,000 results)
|
Select a resource
Filter by
Sort by
|
News Article
April 20, 2012
In two new studies analyzing treatment decisions in late-stage amyotrophic lateral sclerosis (ALS) patients, researchers from the Perelman School of Medicine at the University of Pennsylvania found that delaying one treatment resulted in not living long enough to experience the benefits. They also uncovered polarized preferences among patients regarding the value of an expensive, marginally effective disease-modifying drug. The research will be presented at the American Academy of Neurology's…
Read more
News Article
October 6, 2014
With the tropical rubber tree under threat from climate change and disease, tire manufacturers are reviving efforts to produce latex from a desert shrub
Read more
News Article
February 20, 2014
Three researchers are calling for the FDA to regulate feces as a human tissue rather than a drug to make it easier for doctors to perform fecal transplants.
Read more
News Article
December 5, 2025
RFK Jr’s vaccine advisory panel will be discussing the inclusion of adjuvants in childhood vaccinations today. Here’s what’s at stake
Read more
News Article
February 19, 2026
Tests that could reveal when Alzheimer’s disease will emerge, while promising, are not ready for use in otherwise healthy people, scientists say
Read more
News Article
January 3, 2012
The first changes in the brain of a person with Alzheimer's disease can be observed as much as ten years in advance – ten years before the person in question has become so ill that he or she can be diagnosed with the disease. This is what a new study from Lund University in Sweden has found.
Read more
News Article
March 21, 2012
Alzheimer's disease and other forms of dementia may spread within nerve networks in the brain by moving directly between connected neurons, instead of in other ways proposed by scientists, such as by propagating in all directions, according to researchers who report the finding in the March 22 edition of the journal Neuron.
Read more
News Article
February 18, 2012
Alzheimer's disease drugs now being tested in clinical trials may have potentially adverse side effects. A study with mice suggests the drugs could act like a bad electrician, causing neurons to be miswired and interfering with their ability to send messages to the brain. Ironically, they could impair memory. The findings will be presented Saturday, Feb. 18, at the 2012 AAAS annual meeting.
Read more
News Article
May 16, 2012
ApoE4, a well-known genetic risk factor for Alzheimer's disease triggers a cascade of signaling that ultimately results in leaky blood vessels in the brain, allowing toxic substances to pour into brain tissue in large amounts, scientists report in the journal Nature.
Read more
News Article
April 19, 2012
Researchers at Washington University School of Medicine in St. Louis have shown that brain plaques in mice are associated with disruption of the ability of brain regions to network with each other. This decline parallels earlier results from human studies, suggesting that what scientists learn about Alzheimer's effects on brain networks in the mice will likely be transferable to human disease research.
Read more
|




